Middle East News Dispatch
SEE OTHER BRANDS

The most trusted news from the Middle East

Middle East News Dispatch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Dispatch.

Press releases published on June 11, 2025

BIOFRONTERA INC. IS NEGOTIATING FUNDAMENTAL CHANGES TO ITS COOPERATION WITH BIOFRONTERA AG

BIOFRONTERA INC. IS NEGOTIATING FUNDAMENTAL CHANGES TO ITS COOPERATION WITH BIOFRONTERA AG

WOBURN, Mass., June 11, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company focused on the development and commercialization of photodynamic therapy (PDT), confirms a disclosure by the Management Board of Biofrontera AG on …

More Web3 Games Flock to The Binary Holdings Ecosystem to Reach 169M+ Users Across Telco Channels

More Web3 Games Flock to The Binary Holdings Ecosystem to Reach 169M+ Users Across Telco Channels

The Binary Holdings ecosystem grows further as more Web3 games join OneWave to gain access to 169M+ users across major telecoms, expanding real-world adoption. DUBAI, DUBAI, UNITED ARAB EMIRATES, June 11, 2025 /⁨EINPresswire.com⁩/ -- Article Summary: - …

KFSHRC First in the Middle East to Implant AI-Powered Brain-Sensing Device for Treating Neurological Disorders

KFSHRC First in the Middle East to Implant AI-Powered Brain-Sensing Device for Treating Neurological Disorders

RIYADH, Saudi Arabia, June 11, 2025 (GLOBE NEWSWIRE) -- In a landmark medical achievement, King Faisal Specialist Hospital …

1inch Launches New Core Algorithm, Improving Swap Rates by Up to 6.5%

1inch Launches New Core Algorithm, Improving Swap Rates by Up to 6.5%

DUBAI, United Arab Emirates, June 11, 2025 (GLOBE NEWSWIRE) -- 1inch, a leading DeFi aggregator that connects users to the best trading rates across multiple blockchains, has unveiled a new version of its price route discovery algorithm, Pathfinder. …

Proposed equity fundraising and acquisition of additional licences to create a new West Greenland Hub

Proposed equity fundraising and acquisition of additional licences to create a new West Greenland Hub

Reykjavík, June 11, 2025 (GLOBE NEWSWIRE) -- THIS ANNOUNCEMENT (INCLUDING THE APPENDICES) AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE …

Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders

Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders

CINCINNATI, Ohio, June 11, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (“Onconetix” or the “Company”), a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men’s health …

ZA Miner Launches Global Access to AI-Powered Cloud Mining with $100 Welcome Credit for New Users

ZA Miner Launches Global Access to AI-Powered Cloud Mining with $100 Welcome Credit for New Users

London, UK, June 11, 2025 (GLOBE NEWSWIRE) -- As retail investors increasingly seek reliable, hands-free opportunities in the digital economy, ZA Miner, a next-generation cloud mining platform powered by artificial intelligence and renewable energy, has …

More Lithium Bearing Intersections on Globex’s Lac Escale Royalty Claims

More Lithium Bearing Intersections on Globex’s Lac Escale Royalty Claims

ROUYN-NORANDA, Quebec, June 11, 2025 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang …

De nouvelles intersections de lithium sur les claims à redevance Lac Escale de Globex

De nouvelles intersections de lithium sur les claims à redevance Lac Escale de Globex

ROUYN-NORANDA, Québec, 11 juin 2025 (GLOBE NEWSWIRE) -- ENTREPRISES MINIÈRES GLOBEX INC. (GMX – Bourse de Toronto, G1MN – Bourses de Francfort, Stuttgart, Berlin, Munich, Tradegate, Lang …

BOS Secures an $800,000 Order from an Indian Customer

BOS Secures an $800,000 Order from an Indian Customer

RISHON LE ZION, Israel, June 11, 2025 (GLOBE NEWSWIRE) -- BOS Better Online Solutions Ltd. ("BOS" or the "Company") (NASDAQ: BOSC), a leading integrator of supply chain technologies, announced today that its Supply Chain division has secured an $800,000 …

Cabaletta Bio Announces Pricing of Public Offering of Securities

Cabaletta Bio Announces Pricing of Public Offering of Securities

PHILADELPHIA, June 11, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (“Cabaletta” or the “Company”) (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically …

Aya Gold and Silver Announces Upsize of Previously Announced Bought Deal to $125 Million

Aya Gold and Silver Announces Upsize of Previously Announced Bought Deal to $125 Million

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. The base shelf prospectus is accessible, and the prospectus supplement and any amendment to the foregoing documents will be accessible within one business …

Inspira’s ART100 in Use at Tier-1 U.S. Hospitals, Generating Strong Clinical Interest and Accelerating Sales Discussions

Inspira’s ART100 in Use at Tier-1 U.S. Hospitals, Generating Strong Clinical Interest and Accelerating Sales Discussions

RA'ANANA, Israel, June 11, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira," “Inspira Technologies,” or the "Company"), a pioneer in innovative life-support and diagnostic technologies, announced today that its FDA- …

Fate Therapeutics Announces Updated Clinical Data for FT819 Off-the-shelf CAR T-cell Product Candidate Demonstrating Durability of Drug-free Remission for Severe Lupus Nephritis at EULAR 2025 Congress

Fate Therapeutics Announces Updated Clinical Data for FT819 Off-the-shelf CAR T-cell Product Candidate Demonstrating Durability of Drug-free Remission for Severe Lupus Nephritis at EULAR 2025 Congress

All three patients treated with FT819 following fludarabine-free conditioning regimen for severe lupus nephritis achieve Primary Efficacy Renal Response (PERR); first patient to reach 1-year follow-up continues in drug-free Definition of Remission in SLE ( …

Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears

Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears

SARASOTA, FL, June 11, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced that the U.S. Patent and …

Veru to Participate in the Virtual BTIG Obesity Health Forum

Veru to Participate in the Virtual BTIG Obesity Health Forum

MIAMI, FL, June 11, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced the company …

Lisata Therapeutics to Present at the 2025 BIO International Convention

Lisata Therapeutics to Present at the 2025 BIO International Convention

BASKING RIDGE, N.J., June 11, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other …

OKYO Pharma to Present at the Bio International Convention

OKYO Pharma to Present at the Bio International Convention

LONDON and NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain, a severe ocular condition without an FDA …

Tempest Announces $4.6 Million Registered Direct Offering of Common Stock

Tempest Announces $4.6 Million Registered Direct Offering of Common Stock

BRISBANE, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company with a pipeline of first-in-class1 targeted and immune-mediated therapeutics to fight cancer, today announced that it has …

ImmuneWalk Therapeutics Announces Positive Topline Phase 1 SAD Data for Immunology and Inflammation Drug Candidate IW-601

ImmuneWalk Therapeutics Announces Positive Topline Phase 1 SAD Data for Immunology and Inflammation Drug Candidate IW-601

Study met primary endpoint of safety and tolerability at all doses and secondary pharmacodynamic and pharmacokinetic endpoints after single subcutaneous administration Pharmacodynamics provides mechanistic validation, demonstrating dose-dependent binding …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service